SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers shares are under pressure after its Q3 report showed a surprise loss, shrinking margins, a sequential subscriber decline and a lower profit outlook, despite strong revenue growth. Bears question profitability and execution, while bulls point to international expansion and the upcoming Peptides+ launch as potential growth drivers.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desks quarterly results beat expectations and its next-quarter outlook was stronger than forecast, but shares gave back much of their post-report surge as traders questioned the quality and durability of growth amid flat revenue, weaker margins, and managements cautious tone. The community is split between bulls citing the beat and expanded buyback authorization and bears focused on underlying business weakness and the sharp earnings-call reversal.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines earnings-driven selloff is dominating discussion: revenue beat expectations and the sales outlook rose, but margin compression and unchanged profit guidance fueled concern about whether growth will translate into stronger earnings. Traders are divided between calling the drop an overreaction and warning that pressured margins and debt remain risks.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Reports of an Nvidia board investigation involving CEO Jensen Huang and a woman suspected of being a Chinese spy have fueled concerns about national-security exposure and possible CEO succession risk, though claims of compromised secrets or chip diversion remain unproven. Traders are split between selling amid uncertainty and viewing the controversy as a distraction from Nvidias business fundamentals.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,110,071. The last known price of Bitcoin is 74,895.40905656 USD and is down -0.28 over the last 24 hours. It is currently trading on 12776 active market(s) with $26,892,693,016.04 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Hot U.S. inflation data and renewed bets on Fed rate hikes are weighing on Bitcoin alongside broader risk assets, with traders also citing leveraged long liquidations. The community is split between viewing the pullback as a buying opportunity and expecting further downside, while debating Bitcoins failure to act as an inflation hedge.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Waves Q3 earnings are driving debate: traders point to revenue growth and a large backlog, but worry about softer bookings, delayed conversion of bookings into revenue, continued losses and a stretched valuation. The reaction is broadly bearish, with some investors arguing the commercial pipeline and quantum-computing potential support a longer-term bull case.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Q3 results and raised full-year revenue guidance are driving attention, with traders citing accelerating Eversense sales and commercial traction. Long-term bulls welcome the progress, while skeptics remain concerned about continuing losses, cash needs and management execution.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitize is drawing attention after agreeing to acquire River One to add asset-backed lending capabilities and announcing a share repurchase program, alongside a quarterly update highlighting growth in tokenized assets. Traders are mostly upbeat about the expansion, though some question the undisclosed acquisition terms and execution.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

GTA VIs approaching launch and managements report of exceptionally strong preorders are driving attention, with traders focusing on the games sales potential despite weaker quarterly bookings and unchanged bookings guidance. Some see the demand as a major growth opportunity, while others warn that launch hype may already be priced in and question whether it will produce lasting cash flow.

Pepe (PEPE) is a cryptocurrency launched in 2023and operates on the Ethereum platform. Pepe has a current supply of 413,772,350,095,630.40630647. The last known price of Pepe is 0.00000511 USD and is up 0.93 over the last 24 hours. It is currently trading on 729 active market(s) with $552,678,948.79 traded over the last 24 hours. More information can be found at https://www.pepe.vip/.

Pepe

PEPE is drawing attention for a green rebound and relative strength against a weaker crypto market, prompting traders to speculate that meme-coin momentum may be returning. Bulls are cheering the move and hoping it holds, while skeptics warn it could fade and point to repeated pullbacks around resistance.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-market session. The company's market cap stands at $22.4 million.
WORK Medical Tech Gr (NASDAQ:WOK) sharesread more...

AI Gold Rush and Global Healthcare Deals Erupt

Investor attention continues shifting toward companies positioned at the intersection of artificial intelligence, biotechnology, defense technology, healthcare infrastructure, and digital transformation. $TGNT, $NCRA, $FRSX, $VWAV, $WOK, $STTK

Why Is WORK Medical Technology Stock Falling Friday?

WORK Medical (WOK) stock drops 49% to $0.66 on Friday as investors take profits following historic weekly volatility.read more...

Why Did WOK Stock Skyrocket Nearly 300% In Just 2 Days?

Equity

The company is building infrastructure involving healthcare asset tokenization, AI Agent-to-Agent payments, and stablecoin-enabled settlement for medical assets.

What's Going On With WORK Medical Technology Group Stock Today?

Shares of WORK Medical are rising Monday after the company received manufacturing approval for one of its AI-powered products.read more...

Why Did WOK Stock Surge Over 50% Today?

The company’s unit secured Chinese approval for an AI-powered blood analysis device, and the stock also began trading on a reverse-split basis from Monday.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Neutral Sentiment

<ul class="summary-bullets"><li>On Monday, Work Medical announced a partnership with Shanghai Novabioplus Biotechnology to develop AI-powered healthcare and drug discovery systems.</li><li>The deal includes AI-based projects involving protein design, antibody optimization, enzyme engineering and peptide development.</li><li>Investors also focused on the company’s new “BioToken” concept, which involves creating blockchain-based digital biological assets.</li></ul>Shares of Work Medical Technology Group (WOK) skyrocketed nearly 300% so far this week after the China-based medical device company announced an AI biotech partnership and expanded its push into blockchain-based healthcare infrastructure.<a href="https://stocktwits.com/symbol/WOK">WOK stock</a> surged more than 200% on Monday after the partnership announcement and gained another 70% on Tuesday. The rally continued in Tuesday’s after-hours session, with shares jumping another 70% to become the session’s top after-hours gainer.&nbsp;<h2 class="st-heading-2">WOK AI Healthcare Deal Fuels Rally</h2>The rally accelerated after Work Medical said on Monday that it had struck a deal with Shanghai Novabioplus Biotechnology to develop AI-based healthcare and drug discovery systems using biological datasets. The two companies plan to combine Work Medical’s healthcare AI tech with Novabioplus’ protein research databases and lab platforms to build advanced medical models and improve biotech research and development.According to the company, the partnership strengthens its broader “Healthcare + Web3 + AI” strategy, particularly in biopharmaceutical research. The collaboration includes four major AI-focused projects involving protein structure design, antibody optimization, enzyme engineering and peptide development. The companies said the goal is to use AI to analyze complex biological data, improve molecular design and speed up parts of the drug discovery process.Work Medical said that the partnership could also support the development of AI-assisted protein and antibody therapies by combining its AI algorithms with Novabioplus’ protein datasets and biological research infrastructure.<h2 class="st-heading-2">Work Medical’s ‘BioToken’ Push&nbsp;</h2>WOK shares drew particular attention after the company introduced the concept of “BioTokens,” blockchain-based digital assets tied to biological datasets and protein therapeutics. Work Medical said that the deal with Novabioplus aims to generate AI-driven multimodal biological data “BioTokens” by integrating protein sequences, functional biological data and laboratory datasets into AI models for protein molecular design.The company said the platform is expected to optimize protein structures and improve biological functions, while generating digital biological assets with “assetization potential.” According to Work Medical, the BioToken model could transform biopharmaceutical research outputs into “verifiable and measurable digital assets.”<h2 class="st-heading-2">WOK Deepens Web3 Strategy</h2>The latest AI-biotech announcement comes after several blockchain and tokenization initiatives unveiled by the company this year. Earlier this month, Work Medical said it had been formally awarded a Council Member certificate as a Vice President Unit of the Hong Kong Web3.0 Standardization Association, an organization focused on Web3 standardization research.The announcement came after Hong Kong implemented its stablecoin regulatory framework in August 2025, which Work Medical said accelerated interest among Chinese-listed companies exploring blockchain integration and asset tokenization. Work Medical said it has been advancing a broader strategy involving healthcare real-world asset tokenization, AI Agent-to-Agent payments and stablecoin-enabled cross-border settlement systems to create digital infrastructure for medical assets.The company added that it contributed to an Asset Tokenization Whitepaper released during the Web3.0 Standardization and Globalization Summit in Hong Kong in April. According to Work Medical, the whitepaper established foundational standards for industrial asset digitization and compliance frameworks for healthcare-related digital assets.Work Medical said the company is transitioning from a traditional medical consumables supplier into a builder of “next-generation medical infrastructure powered by AI and blockchain.”<h2 class="st-heading-2">AI Blood Analyzer Added Early Buzz</h2>Investor interest in Work Medical’s AI ambitions had already started building late last year after the commercialization rollout of its AI-Automated Blood Cell Morphology Analyzer in China. In December, the company said that its unit, Hunan Saitumofei Medical Treatment Technology, had entered into a one-year exclusive distribution agreement with Shanghai Benke Medical Technology to distribute the analyzer throughout East China in 2026.The agreement covered Jiangsu Province, Shanghai Municipality and Zhejiang Province and included a minimum annual sales target of 10 million yuan ($1.5 million). The analyzer received Class II medical device manufacturing approval from Chinese regulators in November and uses AI-driven automation and high-resolution digital imaging technology to identify and classify blood cells.According to the company, the system can process up to 150 samples at a time, identify 17 different types of white blood cells and analyze a blood smear in about three minutes on average. Work Medical said the analyzer can store over 350,000 high-definition blood cell images and uses AI-based image analysis tech to make results easier for medical professionals to interpret, while helping reduce potential diagnostic risks.<h2 class="st-heading-2">How Do Retail Traders Feel About WOK?</h2>On Stocktwits, retail sentiment for WOK was ‘extremely bullish’ amid a massive 34,275% surge in message volumes over the past three months. The stock’s retail watcher base has also jumped 30% in a week.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/wok_ss_png_0a50f4ed37.webp" alt="wok ss.png" width="972" height="149"><figcaption>WOK sentiment and message volume as of May 12 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Bleedner/message/653155109">outlined</a> their trading strategy and said, “Out at $9, will look for re-entry tomorrow, but this thing has been wildddd. Up 4,500% since lows of yesterday.”<stembedurl>https://stocktwits.com/Bleedner/message/653155109</stembedurl>Another user said WOK stock could “just run the rest of the week” and compared the rally to an earlier surge in cannabis company AKAN.&nbsp;<stembedurl>https://stocktwits.com/JdNews/message/653155574</stembedurl>WOK stock crashed 99.9% over the past year, but surged 206% since January.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-pops-big-after-hours-on-imminent-leukemia-trial-data-readout-optimism/cZXXrpWRe0T">SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism&nbsp;</a>

WOK stock crashed 99.9% over the past year, but surged 206% since January. (Photo credit: Getty Images)

Work Medical Technology Group Ltd

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

WOK News